SECsense Logo

GlycoMimetics, Inc. 8-K Report: Key Developments on January 13, 2025

$GLYC
Form 8-K
Filed on: 2025-01-13
Source
GlycoMimetics, Inc. 8-K Report: Key Developments on January 13, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: GlycoMimetics, Inc.
  • CIK: 0001253689
  • Location: 9708 Medical Center Drive, Rockville, MD 20850
  • Phone: 240-243-1201
  • State of Incorporation: Delaware (DE)
  1. SEC Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 13, 2025
  • SEC Central Index Key (CIK): 0001253689
  • IRS Employer Identification Number (EIN): 06-1686563
  • Securities Exchange: NASDAQ
  • Trading Symbol: GLYC
  1. Financial Context:
  • Reporting Period: The report pertains to a single day, January 13, 2025.
  • Currency: The financial information is presented in U.S. Dollars (USD).
  • Common Stock: The report involves the common stock of the company, which has a par value of $0.001.
  1. Units of Measurement:
  • Financial metrics are presented in USD, and shares are used as a unit of measurement for stock-related data.

This section indicates that the company has filed a Form 8-K, which typically reports major events that shareholders should know about, on a specific date. The concise nature of the reporting period suggests it could be related to a specific event rather than a financial summary over a longer term. The information is relevant for investors looking to understand recent developments or disclosures by GlycoMimetics, Inc.